Growth Metrics

Arcturus Therapeutics Holdings (ARCT) Current Leases (2019 - 2025)

Historic Current Leases for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q3 2025 value amounting to $4.1 million.

  • Arcturus Therapeutics Holdings' Current Leases rose 2000.0% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 2000.0%. This contributed to the annual value of $3.6 million for FY2024, which is 1756.79% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Current Leases stood at $4.1 million for Q3 2025, which was up 2000.0% from $4.0 million recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Current Leases registered a high of $4.3 million during Q4 2023, and its lowest value of $1.4 million during Q2 2021.
  • Over the past 5 years, Arcturus Therapeutics Holdings' median Current Leases value was $3.8 million (recorded in 2022), while the average stood at $3.3 million.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Current Leases skyrocketed by 15509.1% in 2022 and then plummeted by 1821.43% in 2024.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Current Leases (Quarter) stood at $1.5 million in 2021, then skyrocketed by 152.7% to $3.9 million in 2022, then grew by 10.94% to $4.3 million in 2023, then fell by 17.57% to $3.6 million in 2024, then grew by 16.05% to $4.1 million in 2025.
  • Its Current Leases was $4.1 million in Q3 2025, compared to $4.0 million in Q2 2025 and $3.7 million in Q1 2025.